4/A//SEC Filing
Schaffer Paul W. 4/A
Accession 0001437749-19-018984
CIK 0001029125other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:34 PM ET
Size
6.5 KB
Accession
0001437749-19-018984
Insider Transaction Report
Form 4/AAmended
Schaffer Paul W.
Director
Transactions
- Purchase
Common Stock
2018-05-16+2,000→ 94,420 total - Conversion
Common Stock
2018-05-16+11,756→ 30,665 total
Footnotes (3)
- [F1]Reflects purchase of 5,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- [F2]Pursuant to the "alternate conversion" under the Convertible Promissory Note, approximately $52,902 of outstanding principal and accrued but unpaid interest converted into 11,756 units at a price equal to $4.50 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- [F3]Amended solely to correct balances to reflect reverse stock split effective November 7, 2017.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001652797
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:34 PM ET
- Size
- 6.5 KB